In this issue
Weight loss is associated with sustained improvement of disease activity and cardiovascular risk factors in patients with PsA and obesity
Efficacy and safety of upadacitinib in MTX-naive patients with moderately-to-severely active RA
Associations between PtGA scores and pain, physical function, and fatigue in RA treated with tofacitinib
Outcomes and safety of TNFis in ReA
Risk of serious infection among initiators of TNFis + MTX vs triple therapy for RA
Associations between calcaneal enthesophytes and OA of the hands and feet
Effects of comorbid CVD and diabetes on hand OA, pain, and functional state transitions
CVD effects of biological vs conventional synthetic DMARD therapy in treatment-naive, early RA
Risk factors for hospital admissions related to COVID-19 in patients with AIRD
Trial of upadacitinib or abatacept in RA
Please login below to download this issue (PDF)